Head to Head Survey: Ariad Pharmaceuticals


Ariad Pharmaceuticals and Heat Biologics are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, profitability, valuation, dividends, analyst recommendations and risk. 87.0% of Ariad Pharmaceuticals shares are held by institutional investors.



from Biotech News